ABCB5+ Dermal Mesenchymal Stromal Cells with Favorable Skin Homing and Local Immunomodulation for Recessive Dystrophic Epidermolysis Bullosa Treatment is a research paper published in Stem Cells (2021). On theSindex it has a DataRank of 0. It has been cited 33 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Center for Advancing Translational Sciences
Grant: KL2TR002492
National Center for Advancing Translational Sciences
Grant: UL1TR002494
National Heart, Lung, and Blood Institute
Grant: R01 AR063070
National Institutes of Health
Grant: P30 CA77598
NCI NIH HHS
Grant: P30 CA077598
NEI NIH HHS
Grant: R24 EY028767
RRD VA
Grant: I01 RX000989
NEI NIH HHS
Grant: R01 EY025794
BLRD VA
Grant: I01 BX000516
Zona Family Foundation for EB Research
Richard M. Schulze Family Foundation
EB Charities
MeSH Terms
Keywords
Additional file 1 of Translational development of ABCB5+ dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers
Additional file 1 of Translational development of ABCB5+ dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers
Additional file 2 of Translational development of ABCB5+ dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers
Additional file 2 of Translational development of ABCB5+ dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers
Additional file 3 of Translational development of ABCB5+ dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers
Additional file 3 of Translational development of ABCB5+ dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers